Published in J Genet Genomics on July 01, 2010
Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med (2014) 1.29
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves. J Cancer (2012) 1.12
The tumor microenvironment: a pitch for multiple players. Front Oncol (2013) 1.07
Tumor microenvironment and myeloid-derived suppressor cells. Cancer Microenviron (2012) 1.03
Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches. Stem Cells (2015) 0.97
Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model. Lab Invest (2013) 0.93
Immunotherapy for lung cancer: advances and prospects. Am J Clin Exp Immunol (2016) 0.89
Metastatic cancer stem cells: from the concept to therapeutics. Am J Stem Cells (2014) 0.89
TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis. J Immunother (2012) 0.86
Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activity. Oncoimmunology (2012) 0.77
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget (2016) 0.76
Liposomal clodronate treatment for tumour macrophage depletion in dogs with soft-tissue sarcoma. Vet Comp Oncol (2012) 0.75
The immunological effect of hyaluronan in tumor angiogenesis. Clin Transl Immunology (2015) 0.75
Extracellular matrix mediators of metastatic cell colonization characterized using scaffold mimics of the pre-metastatic niche. Acta Biomater (2016) 0.75
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression. Vaccines (Basel) (2016) 0.75
Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade. Oncoimmunology (2017) 0.75
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut (2011) 2.33
Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett (2008) 1.93
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun (2009) 1.61
MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell (2011) 1.46
Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem (2012) 1.43
Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model. Cancer J (2006) 1.41
HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res (2011) 1.31
miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem (2010) 1.24
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int J Cancer (2011) 1.19
Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int J Cancer (2011) 1.18
Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma. Clin Cancer Res (2014) 1.15
β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. Cancer Res (2013) 1.08
Consice review: Contribution of cancer stem cells to neovascularization. Stem Cells (2011) 1.02
Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells (2012) 1.01
Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Lett (2011) 1.01
FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma. J Pathol (2011) 1.00
Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J Neurooncol (2007) 0.99
ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis. BMC Cancer (2014) 0.97
A novel zebrafish xenotransplantation model for study of glioma stem cell invasion. PLoS One (2013) 0.94
Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. Cancer Res (2014) 0.92
Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model. PLoS One (2012) 0.90
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J Mol Med (Berl) (2013) 0.88
Heterogeneity of mitochondrial membrane potential: a novel tool to isolate and identify cancer stem cells from a tumor mass? Stem Cell Rev (2011) 0.87
The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas. J Pathol (2013) 0.87
Strategies for isolating and enriching cancer stem cells: well begun is half done. Stem Cells Dev (2013) 0.84
Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle. Mol Cancer Ther (2011) 0.83
Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. J Pathol (2014) 0.83
Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol (2016) 0.82
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]. Zhonghua Bing Li Xue Za Zhi (2004) 0.81
Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. Biochem Biophys Res Commun (2006) 0.80
Human umbilical cord blood-derived stromal cells: multifaceted regulators of megakaryocytopoiesis. Cell Cycle (2010) 0.80
Intraparenchymal myofibromatosis of the brain in an adult: report of an unusual case. Neuropathology (2009) 0.78
Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins (F2) isolated from grape seeds. Chem Biol Interact (2009) 0.78
The differentiation-inducing effect of Nordy on HPV-16 subgenes-immortalized human endocervical cells H8. Anticancer Drugs (2008) 0.77
High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma. Medicine (Baltimore) (2015) 0.77
[Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy]. Ai Zheng (2004) 0.76
Resistance to apoptosis should not be taken as a hallmark of cancer. Chin J Cancer (2013) 0.76
Functional characterization of a PEI-CyD-FA-coated adenovirus as delivery vector for gene therapy. Curr Med Chem (2013) 0.75
Protective effects of enalapril, an angiotensin-converting enzyme inhibitor, on multiple organ damage following scald injury in rats. Biotechnol Appl Biochem (2012) 0.75
[Vasculogenic potential of endothelial progenitor cells derived from human umbilical cord blood and their roles in neovascularization of malignant glioma]. Zhonghua Bing Li Xue Za Zhi (2008) 0.75
[Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor]. Yao Xue Xue Bao (2008) 0.75
[Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors]. Ai Zheng (2007) 0.75
[Isolation and identification of tumor stem-like cells from human glioma cell line U87 after treatment of vincristine]. Ai Zheng (2007) 0.75
[Effect of nordy on FPR function of malignant human glioma cell line U87]. Yao Xue Xue Bao (2007) 0.75